PBMs Eye Medicaid Market; AdvancePCS Says Specialty Rx Is Next Focus
Executive Summary
Specialty pharmacy will be the next target for state Medicaid programs looking to control product spend, AdvancePCS VP-Government Programs Christine Nye predicted June 10
You may also be interested in...
Medicaid Rx Prices: 340B Program Offers Better Deal Than PBMs – Attorney
Medicaid programs would save more on drug costs by using the 340B drug pricing mechanism than by using pharmacy benefit managers, Public Hospital Pharmacy Coalition General Counsel William von Oehsen told the 340B Coalition conference July 15 in Washington, D.C
Medicaid Rx Prices: 340B Program Offers Better Deal Than PBMs – Attorney
Medicaid programs would save more on drug costs by using the 340B drug pricing mechanism than by using pharmacy benefit managers, Public Hospital Pharmacy Coalition General Counsel William von Oehsen told the 340B Coalition conference July 15 in Washington, D.C
AdvancePCS Nears End Of Employee Interviews In Government Investigation
The Philadelphia U.S. Attorney's Office will finish AdvancePCS employee interviews in its investigation into the PBM's practices by the end of March, the company told a Jan. 29 analyst call